> top > docs > PubMed:23994798 > annotations
TextAE configuration unavailable!

PubMed:23994798 JSONTXT

Annnotations TAB JSON ListView MergeView

Allie

Id Subject Object Predicate Lexical cue
SS1_23994798_1_0 46-54 expanded denotes T helper
SS2_23994798_1_0 56-58 abbr denotes Th
SS1_23994798_2_0 159-173 expanded denotes Interleukin 17
SS2_23994798_2_0 175-180 abbr denotes IL-17
AE1_23994798_1_0 SS1_23994798_1_0 SS2_23994798_1_0 abbreviatedTo T helper,Th
AE1_23994798_2_0 SS1_23994798_2_0 SS2_23994798_2_0 abbreviatedTo Interleukin 17,IL-17

PubmedHPO

Id Subject Object Predicate Lexical cue
T1 810-819 HP_0003765 denotes psoriasis

Inflammaging

Id Subject Object Predicate Lexical cue
T1 0-45 Sentence denotes The IL-23/IL-17 axis as a therapeutic target.
T2 46-154 Sentence denotes T helper (Th) cells are known to differentiate into several distinct subsets depending on their environment.
T3 155-349 Sentence denotes The Interleukin 17 (IL-17)-producing subset Th17, which was reported and named in 2005, has been extensively analyzed because a strong association with inflammatory disorders has been suggested.
T4 350-540 Sentence denotes The condition in which Th17 cells are differentiated, critical transcription factors, and similarity and difference between mouse and human Th17 cells have been reported one after the other.
T5 541-672 Sentence denotes IL-23, which is believed to be important for the activation of Th17 cells, and IL-17 became promising targets for drug development.
T6 673-860 Sentence denotes In fact, biological drugs that block the IL-23/IL-17 axis have demonstrated to be highly effective against the inflammatory skin disease psoriasis and have been approved for clinical use.
T7 861-1014 Sentence denotes Here an overview and brief history of the basic research on Th17 cells are provided, with the latter full of surprises and unexpected twists in the plot.
T8 1015-1082 Sentence denotes The current state of biological drug development is also described.
T1 0-45 Sentence denotes The IL-23/IL-17 axis as a therapeutic target.
T2 46-154 Sentence denotes T helper (Th) cells are known to differentiate into several distinct subsets depending on their environment.
T3 155-349 Sentence denotes The Interleukin 17 (IL-17)-producing subset Th17, which was reported and named in 2005, has been extensively analyzed because a strong association with inflammatory disorders has been suggested.
T4 350-540 Sentence denotes The condition in which Th17 cells are differentiated, critical transcription factors, and similarity and difference between mouse and human Th17 cells have been reported one after the other.
T5 541-672 Sentence denotes IL-23, which is believed to be important for the activation of Th17 cells, and IL-17 became promising targets for drug development.
T6 673-860 Sentence denotes In fact, biological drugs that block the IL-23/IL-17 axis have demonstrated to be highly effective against the inflammatory skin disease psoriasis and have been approved for clinical use.
T7 861-1014 Sentence denotes Here an overview and brief history of the basic research on Th17 cells are provided, with the latter full of surprises and unexpected twists in the plot.
T8 1015-1082 Sentence denotes The current state of biological drug development is also described.